Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 28, Issue 3, Pages 476-481Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2017.12.014
Keywords
Taraxacum officinale; Butyrolactone; Butanoate; alpha-Glucosidase inhibitor; Mixed-type inhibition
Categories
Funding
- National Foundation of Korea [NRF-2017R1A2B4003888]
Ask authors/readers for more resources
Three novel butyrolactones (1-3) and butanoates (4-6), namely taraxiroside A-F, were isolated from Taraxacum officinale along with twenty-two known compounds (7-28). Their chemical structures were elucidated by interpretation of spectroscopic data and comparison with those of literatures. All isolates were evaluated for their alpha-glucosidase inhibitory activities. Novel compounds 1-6 (IC50 145.3-181.3 mu M) showed inhibitory activities similar to that of acarbose (IC50 179.9 mu M). Compound 7 and 12 were the most potent inhibitor with IC50 values of 61.2 and 39.8 mu M respectively. Compounds 2 and 12 showed as mixed-type inhibition, whereas compound 7 and acarbose showed competitive inhibition. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available